SEC Comment Letter 0000000000-23-008675 to Epsium Enterprise Ltd (EPSM)
Epsium Enterprise Ltd
Date: Aug. 9, 2023 · CIK: 0001883437 · Accession: 0000000000-23-008675
AI Filing Summary & Sentiment
Show Raw Text
United States securities and exchange commission logo
August 9, 2023
Son Tam
Chief Executive Officer
Epsium Enterprise Ltd
Alameda Dr. Carlos D’assumpcao
Edf China Civil Plaza 235-243, 14 Andar P
Macau, SAR China
Re:Epsium Enterprise Ltd
Draft Registration Statement on Form F-1
Submitted July 17, 2023
CIK No. 0001883437
Dear Son Tam:
We have reviewed your draft registration statement and have the following comments. In
some of our comments, we may ask you to provide us with information so we may better
understand your disclosure.
Please respond to this letter by providing the requested information and either submitting
an amended draft registration statement or publicly filing your registration statement on
EDGAR. If you do not believe our comments apply to your facts and circumstances or do not
believe an amendment is appropriate, please tell us why in your response.
After reviewing the information you provide in response to these comments and your
amended draft registration statement or filed registration statement, we may have additional
comments.
Draft Registration Statement on Form F-1 submitted July 17, 2023
Cover page
1.We note your disclosure that although you believe your corporate structure is stable
without any interference from current applicable laws in PRC, Hong Kong, or Macau, you
"face risks and uncertainties associated with the complex and evolving PRC laws and
regulations and the economic conditions of the PRC because [y]our business operations
rely on the economic growth of the PRC and the smooth functioning of the PRC
commercial participants in [y]our industry." Please revise to disclose that this structure
involves unique risks to investors and acknowledge that Chinese regulatory authorities
could disallow this structure, which would likely result in a material change in your
FirstName LastNameSon Tam
Comapany NameEpsium Enterprise Ltd
August 9, 2023 Page 2
FirstName LastNameSon Tam
Epsium Enterprise Ltd
August 9, 2023
Page 2
operations and/or a material change in the value of the securities you are registering for
sale, including that it could cause the value of such securities to significantly decline or
become worthless. Provide a cross-reference to your detailed discussion of risks facing the
company and the offering as a result of this structure.
2.Please revise your disclosure about the various legal and operational risks and
uncertainties relating to your operations in Macau to make clear whether these risks could
result in a material change in your operations and/or the value of the securities you are
registering for sale or could significantly limit or completely hinder your ability to offer or
continue to offer securities to investors and cause the value of such securities to
significantly decline or be worthless. Your disclosure should address how recent
statements and regulatory actions by China’s government, such as those related to data
security or anti-monopoly concerns, have or may impact your ability to conduct business,
accept foreign investments, or list on a U.S. or other foreign exchange. Your prospectus
summary should address, but not necessarily be limited to, the risks highlighted on the
prospectus cover page.
3.Please revise to more clearly disclose how you will refer to the holding company and
subsidiaries. In this regard, we note your disclosure on the cover that references
to "Epsium” or “Epsium BVI” are to EPSIUM ENTERPRISE LIMITED; and “we”, “us”,
“our Company”, “the Company”, or “our” are to Epsium HK and its subsidiaries.
However, on page ii, you state that “we”, “us”, “our company”, or “our” are to EPSIUM
ENTERPRISE LIMITED, together as a group with its subsidiaries.
4.We note that you have operations located in Hong Kong. Please discuss in future filings,
the applicable laws and regulations in Hong Kong as well as the related risks and
consequences. Examples of applicable laws and regulations include, but are not limited to:
•Enforceability of civil liabilities in Hong Kong;
•China’s Enterprise Tax Law ("EIT Law");
•Regulatory actions related to data security or anti-monopoly concerns in Hong Kong
and their potential impact on your ability to conduct business, accept foreign
investment or list on a U.S./foreign exchange; and
•Risk factor disclosure explaining whether there are laws/regulations in Hong Kong
that result in oversight over data security, how this oversight impacts the company’s
business, and to what extent the company believes that it is compliant with the
regulations or policies that have been issued.
5.We note your disclosure about how cash is transferred throughout the organization. Please
revise to provide examples of the "intra-group transactions," by way of which you state
cash is transferred through your organization. Quantify any transfers, dividends, or
distributions that have been made to date between the holding company and its
subsidiaries, including the three cash transfers between the Company and the operating
entity during the fiscal years ended 2022, and 2021. Discuss whether there are limitations
on your ability to transfer cash between you, your subsidiaries, or investors. In addition,
please amend your disclosure here and in the summary risk factors and risk factors
FirstName LastNameSon Tam
Comapany NameEpsium Enterprise Ltd
August 9, 2023 Page 3
FirstName LastNameSon Tam
Epsium Enterprise Ltd
August 9, 2023
Page 3
sections to state that, to the extent cash or assets in the business is in the PRC/Hong Kong
or a PRC/Hong Kong entity, the funds or assets may not be available to fund operations
or for other use outside of the PRC/Hong Kong due to interventions in or the imposition of
restrictions and limitations on the ability of you or your subsidiaries by the PRC
government to transfer cash or assets. On the cover page, provide cross-references to each
of these other discussions in the prospectus summary, summary risk factors and risk
factors.
6.Please revise here to state, as you do on page 5, that there are no specific cash
management policies and procedures in place that dictate how funds are transferred
through your organization. Provide a cross-reference on the cover page to the discussion
of this issue in the prospectus summary.
7.We note your disclosure that you will be a "controlled company" and that Mr. Son I Tam,
your Chief Executive Officer, Chief Financial Officer, chairman of the Board of Directors,
and principal shareholder, and his affiliates own and hold more than 50% of your
outstanding Ordinary Shares. Please also disclose Mr. Tam's ability to control matters
requiring shareholder approval, including the election of directors, amendment of
organizational documents, and approval of major corporate transactions, such as a change
in control, merger, consolidation, or sale of assets. Make conforming changes throughout
the document and expand your risk factors disclosure on page 36 to acknowledge the risks
to shareholders that arise from this control, including the anti-takeover effects of this
ownership.
About this Prospectus
Conventions that Apply to this Prospectus, page ii
8.We note that your definition of China or the PRC excludes the special administrative
regions of Hong Kong, Macau, and Taiwan and your disclosure that reference to laws and
regulations of China or the PRC are only to such laws and regulations of mainland
China. Please revise here or elsewhere in this prospectus, as applicable, to disclose that the
same legal and operational risks associated with operations in China
also apply to operations in Hong Kong/Macau.
Prospectus Summary, page 1
9.We note your diagram of the company’s corporate structure, identifying the person or
entity that owns the equity in each depicted entity. Please revise to identify clearly the
entity in which investors are purchasing their interest. Describe the relevant contractual
agreements, if any, between the entities, including those that affect the manner in which
you operate, impact your economic rights, or impact your ability to control your
subsidiaries. Disclose the uncertainties regarding the challenges the company may face
enforcing any such contractual agreements due to legal uncertainties and jurisdictional
limits. Identify clearly the entity(ies) in which the company’s operations are conducted.
FirstName LastNameSon Tam
Comapany NameEpsium Enterprise Ltd
August 9, 2023 Page 4
FirstName LastNameSon Tam
Epsium Enterprise Ltd
August 9, 2023
Page 4
Summary of Risk Factors
Risks Related to the PRC and Risks Related to Doing Business in Macau, page 4
10.Please revise to expand your disclosure and discuss the risk that the Chinese government
may intervene or influence your operations at any time, or may exert more control over
offerings conducted overseas and/or foreign investment in China-based issuers, which
could result in a material change in your operations and/or the value of the securities you
are registering for sale. Acknowledge any risks that any actions by the Chinese
government to exert more oversight and control over offerings that are conducted overseas
and/or foreign investment in China-based issuers could significantly limit or completely
hinder your ability to offer or continue to offer securities to investors and cause the value
of such securities to significantly decline or be worthless.
Cash Flow through Organization, page 5
11.Please revise to expand your disclosure about restrictions on your ability to transfer cash
between entities, across borders, and to U.S. investors, including any restrictions on
foreign exchange.
Any significant disruption or interruption in the supply chain may adversely affect the Operating
Entity..., page 14
12.Please revise to update your risks characterized as potential if recent supply chain
disruptions have impacted your operations. In this regard, we note your disclosure on page
49 indicating that during 2022, the COVID-19 pandemic impacted supply chains and
global financial markets and that governments have imposed laws that impacted the
Operating Entity’s operations, financial condition and demand for its products, but also
impacted the Operating Entity’s overall ability to react quickly enough to mitigate the
impact of these laws and regulations. In addition, expand your disclosure to explain
whether any mitigation efforts introduce new material risks, including those related to
product quality, reliability, or regulatory approval of products.
Risk Factors, page 14
13.We note your risk factors on page 19 regarding your reliance on three major suppliers.
You state that "[b]ecause of this, [you] may not be able to find replacements or
immediately transition to alternative suppliers in the event [you] need to do so;" and that
"[i]f [you] lose one or more of the suppliers, [y]our operation may be disrupted, and the
results of operations may be adversely and materially impacted;" and "[i]f [you] are
unable to source products or services at favorable prices, [y]our net revenues and gross
profit margins may be materially and adversely affected." However, you also state
that "due to the abundance of competitive suppliers, [you] would be able to find a suitable
replacement in a timely manner if [you] were to lose any of [y]our existing
suppliers." Please revise these disclosures to resolve the apparent inconsistency and to
clarify the extent to which you are substantially dependent on any contract associated with
FirstName LastNameSon Tam
Comapany NameEpsium Enterprise Ltd
August 9, 2023 Page 5
FirstName LastNameSon Tam
Epsium Enterprise Ltd
August 9, 2023
Page 5
your operations. If you are so dependent, please file any such agreements as exhibits.
Refer to Item 601(b)(10) of Regulation S-K.
14.We note your disclosure on page 3 that "[f]or the fiscal years 2020, 2021, and 2022, sales
to [y]our major customers accounted for 45.2%, 47.9%, and 48.8% of our total revenues,
respectively." To the extent you are materially dependent on these clients, please describe
the material terms of these agreements and file them as exhibits or tell us why you are not
required to do so. Refer to Part 1, Item 4 of Form F-1 and Part 1, Item 4.B.6 of Form 20-F.
Also, provide risk factor disclosure on your dependence on a limited number of
customers, if applicable. Refer to Item 3 of Form F-1.
Uncertainties with respect to the PRC legal system could materially and adversely affect us...,
page 26
15.Please revise your discussion about the PRC government's significant oversight and
discretion over the conduct of your business to describe any material impact that
such intervention or control has or may have on the value of your securities. We remind
you that, pursuant to federal securities rules, the term “control” (including the terms
“controlling,” “controlled by,” and “under common control with”) means “the possession,
direct or indirect, of the power to direct or cause the direction of the management and
policies of a person, whether through the ownership of voting securities, by contract, or
otherwise.
Recent greater oversight by the Cyberspace Administration of China..., page 28
16.You state that "[t]here remains uncertainty as to how the Cybersecurity Review Measures
and the Security Administration Draft will be interpreted or implemented and whether the
PRC regulatory agencies, including the CAC, may adopt new laws, regulations, rules, or
detailed implementation and interpretation related to the Cybersecurity Review Measures
and the Security Administration Draft." This uncertainty seems to conflict with your
statement without qualification that neither you "nor the operating entity is subject to
cybersecurity review by the CAC." Please revise or advise. Make conforming changes on
the cover page where you provide similar disclosure.
Enforceability of Civil Liabilities, page 41
17.Please revise to clarify the location of your directors, officers or members of senior
management. Identify the individuals located in the PRC/Hong Kong.
Management's Discussion and Analysis of Financial Condition and Results of Operation
Liquidity and Capital Resources, page 52
18.To the extent material to an understanding of your liquidity, please discuss here your
related party loans and, if applicable, address the potential risks and consequences of such
loans on your liquidity. In this regard, we note disclosure on page 93 about various cash
advancements to, and loans from, Mr. Tam that were conducted without contracts and
FirstName LastNameSon Tam
Comapany NameEpsium Enterprise Ltd
August 9, 2023 Page 6
FirstName LastName
Son Tam
Epsium Enterprise Ltd
August 9, 2023
Page 6
have been interest-free with no repayment terms. We also note the general prohibition on
loans to executives under Section 13(k) of the Securities Exchange Act of 1934.
Epsium Enterprise Limited Consolidated Financial Statements
2. Summary of Significant Accounting Policies
Revenue Recognition, page F-9
19.Your disclosure on page 69 of the "Business" section of the filing indicates that you
import and sell a broad range of premium beverages, primarily alcoholic beverages and in
2022 a small quantity of tea and fruit juice. You also indicate that the alcoholic beverages
you sell include Chinese liquor, French Cognac, Scottish Whiskey, fine wine, Champagne
and other miscellaneous beverage alcohol. Please revise the notes to your financial
statements to disclose revenues associated with each of your principal products or group
of similar products for each period presented in your financial statements or explain why
you do not believe this is required. Refer to the guidance in ASC 280-10-50-40.
13. Subsequent Events, page F-17
20.Please revise the notes to your audited financial statements to disclose the nature and
significant terms of the related party transactions with Mr. Tam, your Chief Executive
officer and Chief Financial Officer during 2023 as described on page 93 under the heading
"Related Party T